Procurement Summary
Country : Brazil
Summary : Acquisition of Medicines for the Treatment of Post-Covid-19 Patients, Funding Based on Complementary Law No. 172, of April 15, 2020 Account: 16.068-7, Covid-19 Resources.
Deadline : 08 Dec 2023
Other Information
Notice Type : Tender
TOT Ref.No.: 92744199
Document Ref. No. : 37/2023
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Medicines for the treatment of post-COVID-19 patients, costing based on Complementary Law No. 172, of April 15, 2020 Account: 16.068-7, COVID-19 Resources.
UASG Code: 984273
Notice from: 11/24/2023 from 08:00 to 17:59 pm
Delivery of19981d172c851bd4e8a1788d5726c2d3Proposal: from 11/24/2023 at 08:00
ACEBROPHYLLINE, CONCENTRATION 5 MG/ML, PHARMACEUTICAL FORM SYRUP
Quantity: 300
ACEBROPHYLLINE, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM SYRUP
Quantity: 600
BECLOMETHASONONE DIPROPIONATE, CONCENTRATION 250 MCG/DOSE, PHARMACEUTICAL FORM ORAL AEROSOL, CARACT19981d172c851bd4e8a1788d5726c2d3ADDITIONAL ERISTICS WITH INHALER
Quantity: 300
BUDESONIDE, NASAL AEROSOL PRESENTATION, CONCENTRATION 32MCG/DOSE, ADDITIONAL CHARACTERISTICS BOTTLE WITH DOSING VALVE
Quantity: 200
BUDESONIDE, NASAL AEROSOL PRESENTATION, CONCENTRATION 50MCG/DOSE, CHARACTERISTICS ADDITIONAL BOTTLE WITH VALVEDOSING MACHINE
Quantity: 200
BUDESONIDE, NASAL AEROSOL PRESENTATION, CONCENTRATION 64MCG/DOSE, ADDITIONAL CHARACTERISTICS BOTTLE WITH DOSING VALVE
Quantity: 200
CINARIZINE, DOSAGE 75 MG
Quantity: 1000
CALCIUM CARBONATE, ASSOCIATED COMPOSITION WITH VITAMIN D3, CONCENTRATION 500 MG 219981d172c851bd4e8a1788d5726c2d300 MG, PHARMACEUTICAL FORM CHEWABLE TABLET
Quantity: 400
DExCHLORPHENYRAMINE MALEATE, COMPOSITION ASSOCIATED WITH BETAMETHASONE, CONCENTRATION 2MG/ML 0.25 MG/ML, PHARMACEUTICAL FORM ORAL SOLUTION DROPS
Quantity: 1000
DIPYRONE SODIUM, COMPOSITION A ASSOCIATED WITH CAFFEINE AND DIHYDROERGOTAMINE, CONCENTRATION19981d172c851bd4e8a1788d5726c2d3350 MG 100 MG 1 MG
Quantity: 300
DIPIRONE SODIUM, DOSAGE 500 MG
Quantity: 50
FORMOTEROL FUMARATE, COMPOSITION ASSOCIATED WITH FLUTICASONE, CONCENTRATION 12 MCG 250 MCG, PHARMACEUTICAL FORM CAPSULE INHALER POWDER, CHARACTERISTICS A ADDITIONALS WITH INHALER BOTTLE
Quantity: 50
MEDICINAL ExTRACT, PRI19981d172c851bd4e8a1788d5726c2d3ACTIVE INGREDIENT GINKGO BILOBA, CONCENTRATION 120 MG
Quantity: 350
GLICLAZIDE, CON...
Documents
Tender Notice